PDEX pro-dex.com: Company Value to Revenue

Official company branding of Pro-Dex (PDEX)

Pro-Dex, Inc. (PDEX) profitability is based on long-term OEM contracts within the robot-assisted surgery segment. The EV/Sales multiple illustrates market sentiment, where 2646.39 captures the current state of the parameter. Company revenues depend on government budgets and regulatory reviews. High integration into big-medtech systems and FDA certification ensure exceptional customer loyalty.

pro-dex.com (PDEX): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/19/2026

PDEX (Pro-Dex Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:
- company stock capitalization data:
Initial company analysis:pro-dex.com
Manufactured products of Pro-Dex Corp

To isolate the fundamental stability of Pro-Dex, Inc. (PDEX) from market noise, a metric is used that determines business value through the sum of market capitalization and net debt relative to sales volume. An analysis of the EV/Sales ratio allows for an assessment of the market value of every dollar of revenue without distortions from debt load. The stability of this chart is supported by the effective implementation of ESG standards and the minimization of production waste within the medical equipment segment.

Competitor analysis

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|Company Value to Revenue Ratio XRAY|LMAT (LeMaitre Corp) - EV/Sales Multiple|ATRC (AtriCure Inc) - Enterprise Value-to-Revenue Coefficient|EV/Sales Multiple STAA|NAGE (ChromaDex Corp) - Business Value to Revenue|ZimVie Inc. - Company Value to Revenue|Total Company Value-to-Revenue Ratio angiodynamics.com (ANGO)|CERS - Enterprise Value-to-Revenue Ratio|TKNO - EV/Sales Multiple|Monogram Technologies Inc (MGRM) - Enterprise Value-to-Revenue Ratio|STSS - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio InfuSystem Holdings, Inc.|Enterprise Value-to-Revenue Multiple Utah Medical Products UTMD|EV/Sales Multiple KRMD|Total Company Value-to-Revenue Ratio Nyxoah, S.A.|Microbot Medical Inc - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple